3F-NEH
Tools
Actions
General
Print/export
In other projects
Appearance
Source: Wikipedia, the free encyclopedia.
Substituted cathinone stimulant drug
![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H20FNO |
Molar mass | 237.318 g·mol−1 |
3D model (JSmol) | |
|
3F-NEH (3-Fluoro-N-Ethylhexedrone) is a recreational designer drug from the substituted cathinone family, with stimulant effects. It was first identified in Sweden in October 2020.[1]
See also
- 3-Fluoromethamphetamine
- 3-Fluoromethcathinone
- 3F-NEB
- 3F-PiHP
- 3F-PVP
- 3F-Phenmetrazine
- N-Ethylhexedrone
- N-Ethylhexylone
References
- ^ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=3F-NEH&oldid=1244151661"